188 related articles for article (PubMed ID: 14608531)
1. The origin of the neoplastic stromal cell in giant cell tumor of bone.
Wülling M; Delling G; Kaiser E
Hum Pathol; 2003 Oct; 34(10):983-93. PubMed ID: 14608531
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
Huang L; Xu J; Wood DJ; Zheng MH
Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
[TBL] [Abstract][Full Text] [Related]
3. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Kumta SM; Huang L; Cheng YY; Chow LT; Lee KM; Zheng MH
Life Sci; 2003 Aug; 73(11):1427-36. PubMed ID: 12850503
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the UCHL1 gene in giant cell tumors of bone.
Fellenberg J; Lehner B; Witte D
Int J Cancer; 2010 Oct; 127(8):1804-12. PubMed ID: 20104524
[TBL] [Abstract][Full Text] [Related]
6. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
Cowan RW; Singh G; Ghert M
J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
[TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone.
Rao VH; Singh RK; Delimont DC; Schaefer GB; Bridge JA; Neff JR; Sanger WG; Sappenfield JW; Buehler BA; Finnell RH
J Interferon Cytokine Res; 1999 Oct; 19(10):1207-17. PubMed ID: 10547161
[TBL] [Abstract][Full Text] [Related]
10. Histogenetic characterization of giant cell tumor of bone.
Salerno M; Avnet S; Alberghini M; Giunti A; Baldini N
Clin Orthop Relat Res; 2008 Sep; 466(9):2081-91. PubMed ID: 18543051
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Rao VH; Singh RK; Delimont DC; Finnell RH; Bridge JA; Neff JR; Garvin BP; Pickering DL; Sanger WG; Buehler BA; Schaefer GB
Int J Oncol; 1999 Feb; 14(2):291-300. PubMed ID: 9917505
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.
Liao TS; Yurgelun MB; Chang SS; Zhang HZ; Murakami K; Blaine TA; Parisien MV; Kim W; Winchester RJ; Lee FY
J Orthop Res; 2005 Jan; 23(1):203-9. PubMed ID: 15607894
[TBL] [Abstract][Full Text] [Related]
13. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts.
Zheng MH; Robbins P; Xu J; Huang L; Wood DJ; Papadimitriou JM
Histol Histopathol; 2001 Jan; 16(1):297-307. PubMed ID: 11193206
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast lineage properties in giant cell tumors of bone.
Murata A; Fujita T; Kawahara N; Tsuchiya H; Tomita K
J Orthop Sci; 2005 Nov; 10(6):581-8. PubMed ID: 16307183
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
[TBL] [Abstract][Full Text] [Related]
16. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
17. Properties of the stromal cell in giant cell tumor of bone.
Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of bone: frequent actin immunoreactivity in stromal tumor cells.
Watanabe K; Tajino T; Kusakabe T; Saitoh A; Suzuki T
Pathol Int; 1997 Oct; 47(10):680-4. PubMed ID: 9361101
[TBL] [Abstract][Full Text] [Related]
19. Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis.
Robinson D; Segal M; Nevo Z
Pathobiology; 2002-2003; 70(6):333-42. PubMed ID: 12865629
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Rao VH; Singh RK; Bridge JA; Neff JR; Schaefer GB; Delimont DC; Dunn CM; Sanger WG; Buehler BA; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1997 Jul; 15(4):400-9. PubMed ID: 9219728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
